Knepp V M, Hadgraft J, Guy R H
Department of Pharmaceutical Chemistry, University of California at San Francisco.
Crit Rev Ther Drug Carrier Syst. 1987;4(1):13-37.
Transdermal drug delivery has, in recent years, attracted considerable interest. However, despite the obvious advantages of this novel route of drug administration to achieve systemic therapeutic effect, there remain important, and sometimes severe, limitations on the physiochemical and pharmacological properties of the agent to be delivered. This article reviews the present status and accomplishments of transdermal drug delivery. The benefits, disadvantages, and, as yet, unresolved problems inherent to drug input via the skin are addressed. Deficiencies in our knowledge of the percutaneous absorption process in man are identified, and approaches to elucidate these unknowns are discussed. Finally, with respect to the future potential of transdermal drug delivery, experimental and modeling techniques, which can be employed to assess the feasibility and promise of a therapeutic candidate, are described and illustrated with pertinent examples.
近年来,经皮给药已引起了广泛关注。然而,尽管这种新型给药途径在实现全身治疗效果方面具有明显优势,但对于待递送药物的理化性质和药理性质仍存在重要且有时是严重的限制。本文综述了经皮给药的现状与成果。探讨了通过皮肤给药所固有的益处、缺点以及尚未解决的问题。明确了我们在人体经皮吸收过程知识方面的不足,并讨论了阐明这些未知因素的方法。最后,关于经皮给药的未来潜力,介绍了可用于评估治疗候选药物可行性和前景的实验及建模技术,并通过相关实例进行说明。